xct slc7a11 (Cell Signaling Technology Inc)
Structured Review
Xct Slc7a11, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 164 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+slc7a11/xCT%2FSLC7A11+Antibody/10__3390_slash_antiox15101300-96-32-34
Average 96 stars, based on 164 article reviews
Images
Related Articles
other:Article Title: Ginkgolic acid targets HSPA8 to trigger ferroptosis in hepatocellular carcinoma via chaperone-mediated autophagy-dependent GPX4 degradation Article Snippet: The following antibodies were used: anti-GPX4 (Immunoway, PT0621R, 1:1000, AB_3716555), anti-HSPA8 (Huabio, ET1602-33, 1:1000, AB_3069646), anti-ACTB (Huabio, HA722023, 1:20000, AB_3096833), Article Title: p53 and fatty acids collaborate to trigger ferroptosis via the FBXO2-FABP5 axis in colorectal cancer. Article Snippet: The Article Title: p53 and fatty acids collaborate to trigger ferroptosis via the FBXO2-FABP5 axis in colorectal cancer Article Snippet: The anti-Flag antibody (F1804) was purchased from Sigma-Aldrich (St. Louis, MO, USA). Article Title: APR-246 drives ROS-dependent ferroptosis and apoptosis and enhances anti-PD-1 efficacy in bladder cancer. Article Snippet: Primary antibodies were as follows: anti-SLC7A11 (cat. no. 98051S), anti-GPX4 (cat. no. 52455S), and anti-PARP (cat. no. 9532S) ( Article Title: TCF3 activates super-enhancer-driven TRIB2 overexpression to suppress ferroptosis and promote hepatoblastoma proliferation. Article Snippet: The primary antibodies used in this study were Western Blot:Article Title: Phase Separation of NFIB Suppresses SLC3A2-Mediated Ferroptosis in Castration-Resistant Prostate Cancer. Article Snippet: .. The primary antibodies used in Western blotting included anti-NFIB (1:1000, Abcam), Plasmid Preparation:Article Title: HER2-dependent paraptosis and ferroptosis induction by cannabidiol in breast cancer cells. Article Snippet: HER2 (human epidermal growth factor receptor 2) is a well-established oncogenic driver and therapeutic target in breast cancer.. Cannabidiol (CBD), a non-psychoactive phytocannabinoid, has demonstrated anticancer potential, yet its mechanisms of action in HER2-positive breast cancer remain insufficiently characterized.. In this study, we examined the effects of CBD on HER2-positive (SK-BR-3, BT-474) and HER2-negative (MCF-7, MDAMB-231) breast cancer cell lines, with a focus on its interaction with HER2. Cell-Signaling:Article Title: Elevated SLC3A2 Expression Promotes the Progression of Gliomas and Enhances Ferroptosis Resistance through the AKT/NRF2/GPX4 Axis Article Snippet: The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Biosharp) supplemented with 10% fetal bovine serum (ExCell) and penicillin-streptomycin solution (Solarbio) at a 37°C CO 2 incubator. .. The antibodies used in this study included anti-CD98 (PA5-96401, Invitrogen), Marker:Article Title: Elevated SLC3A2 Expression Promotes the Progression of Gliomas and Enhances Ferroptosis Resistance through the AKT/NRF2/GPX4 Axis Article Snippet: The cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM; Biosharp) supplemented with 10% fetal bovine serum (ExCell) and penicillin-streptomycin solution (Solarbio) at a 37°C CO 2 incubator. .. The antibodies used in this study included anti-CD98 (PA5-96401, Invitrogen), |
